Infective complications after minor operations in patients infected with HIV: role of CD4 lymphocytes in prognosis. NLM AIDSLINE Important note: Information in this article was accurate in 1996. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Infective complications after minor operations in patients infected with HIV: role of CD4 lymphocytes in prognosis.

Eur J Surg. 1995 Oct;161(10):721-3. Unique Identifier : AIDSLINE MED/96136956
Emparan C; Iturburu IM; Portugal V; Apecechea A; Bilbao JE; Mendez JJ; Department of Surgery, Universidad del Pais Vasco, General; Surgery B, Hospital de Basurto, Bilbao, Spain.


Abstract: OBJECTIVE: To find out the incidence of wound infection in patients with HIV and reduced counts of CD4 lymphocytes. DESIGN: Open study. SETTING: University hospital, Spain. SUBJECTS: 70 patients with HIV infection and enlarged lymph nodes. INTERVENTIONS: Biopsy of lymph nodes and withdrawal of a sample of blood for counts of CD4 lymphocytes and neutrophils. MAIN OUTCOME MEASURE: Development of infection at the biopsy site, and correlation of infecting organism with culture taken at the time of biopsy. RESULTS: Patients were divided into three groups depending on their CD4 count: more than 500 cells/ml (n = 26), 200-500 cells/ml (n = 24), and less than 200 cells/ml (n = 20). Their neutrophil counts were 5.1, 3.8, and 2.5 x 10(9)/1, respectively. There were found four wound infections (6%); 2 were in the group with more than 500 CD4 cells/ml, and these were caused by Staphylococcus aureus (which had been grown from nodes in 6 patients at the time of biopsy). The other 2 were in the group with less than 500 cells/ml and these were caused by Mycobacterium tuberculosis; cultures of the nodes had shown Staphylococcus epidermidis (n = 3) and M tuberculosis (n = 17). There were no infections in the group with 200-500 CD4 cells/ml, in which S epidermidis (n = 5) and M tuberculosis (n = 8) had been cultured from the lymph nodes. CONCLUSIONS: The CD4 count was of no prognostic importance in the development of wound infection, but severe depression of the CD4 count may increase the risk of atypical wound infections.
Keywords: Biopsy CD4 Lymphocyte Count CD4-Positive T-Lymphocytes/*PHYSIOLOGY Human HIV Infections/*IMMUNOLOGY Leukocyte Count Lymph Nodes/MICROBIOLOGY/PATHOLOGY Neutrophils Prognosis Staphylococcal Infections/IMMUNOLOGY/MICROBIOLOGY Surgical Wound Infection/*IMMUNOLOGY/MICROBIOLOGY Tuberculosis/IMMUNOLOGY/MICROBIOLOGY JOURNAL ARTICLEKWDbiopsycd4lymphocytecountcd4-positivet-lymphocytes/KWDphysiologyhumanhivinfections/KWDimmunologyleukocytecountlymphnodes/microbiology/pathologyneutrophilsprognosisstaphylococcalinfections/immunology/microbiologysurgicalwoundinfection/KWDimmunology/microbiologytuberculosis/immunology/microbiologyjournalarticle
960530
M9651061

Copyright © 1996 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1996. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1996. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .